Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Alzheimer's Disease

Free Subscription 20.09.2021 1 Alzheimers Dement 1 Am J Alzheimers Dis Other Demen 1 BMC Neurosci 1 Dement Geriatr Cogn Disord 18 J Alzheimers Dis 1 J Neurol Neurosurg Psychiatry 1 Nat Rev Neurol 2 Neurobiol Aging 3 Neurochem Res 1 Neurologia (Engl Ed) 2 Neurology 1 Neurosci Lett 1 PLoS Biol 1 PLoS Genet

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Alzheimers Dement

1. PHILLIPS JS, Nitchie FJ 4th, Da Re F, Olm CA, et al
   Rates of longitudinal change in (18) F-flortaucipir PET vary by brain region, cognitive impairment, and age in atypical Alzheimer's disease.
   Alzheimers Dement. 2021 Sep 13. doi: 10.1002/alz.12456.
   PubMed         Abstract available
   
   

   
   Am J Alzheimers Dis Other Demen

2. HENDRIKS I, Demetrio R, Meiland FJM, Chattat R, et al
   Value of Personalized Dementia-Specific Quality of Life Scales: An Explorative Study in 3 European Countries.
   Am J Alzheimers Dis Other Demen. 2021;36:15333175211033721.
   PubMed         Abstract available
   
   

   
   BMC Neurosci

3. WEN J, Zhao M, Sun W, Cheng X, et al
   Uptake of Abeta by OATPs might be a new pathophysiological mechanism of Alzheimer disease.
   BMC Neurosci. 2021;22:53.
   PubMed         Abstract available
   
   

   
   Dement Geriatr Cogn Disord

4. HONG YJ, Han HJ, Youn YC, Park KW, et al
   Effects of Body Weight on the Safety of High-Dose Donepezil in Alzheimer's Disease: Post hoc Analysis of a Multicenter, Randomized, Open-Label, Parallel Design, Three-Arm Clinical Trial.
   Dement Geriatr Cogn Disord. 2021 Sep 10:1-7. doi: 10.1159/000518470.
   PubMed         Abstract available
   
   

   
   J Alzheimers Dis

5. EDLUND AK, Chen K, Lee W, Protas H, et al
   Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE varepsilon3/varepsilon4 Carriers.
   J Alzheimers Dis. 2021;81:339-354.
   PubMed         Abstract available
   
   
6. UMEGAKI H, Suzuki Y, Komiya H, Watanabe K, et al
   Frequencies and Neuropsychological Characteristics of Errors in the Clock Drawing Test.
   J Alzheimers Dis. 2021;82:1291-1300.
   PubMed         Abstract available
   
   
7. GONZALEZ-ALCAIDE G, Fernandez-Rios M, Redolat R, Serra E, et al
   Research on Emotion Recognition and Dementias: Foundations and Prospects.
   J Alzheimers Dis. 2021;82:939-950.
   PubMed         Abstract available
   
   
8. GROBER E, Qi Q, Kuo L, Hassenstab J, et al
   The Free and Cued Selective Reminding Test Predicts Braak Stage.
   J Alzheimers Dis. 2021;80:175-183.
   PubMed         Abstract available
   
   
9. STONNINGTON CM, Wu J, Zhang J, Shi J, et al
   Improved Prediction of Imminent Progression to Clinically Significant Memory Decline Using Surface Multivariate Morphometry Statistics and Sparse Coding.
   J Alzheimers Dis. 2021;81:209-220.
   PubMed         Abstract available
   
   
10. RHODES E, Insel PS, Butters MA, Morin R, et al
    The Impact of Amyloid Burden and APOE on Rates of Cognitive Impairment in Late Life Depression.
    J Alzheimers Dis. 2021;80:991-1002.
    PubMed         Abstract available
    
    
11. PEIRA E, Grazzini M, Bauckneht M, Sensi F, et al
    Probing the Role of a Regional Quantitative Assessment of Amyloid PET.
    J Alzheimers Dis. 2021;80:383-396.
    PubMed         Abstract available
    
    
12. LI X, Shen M, Jin Y, Jia S, et al
    Validity and Reliability of the New Chinese Version of the Frontal Assessment Battery-Phonemic.
    J Alzheimers Dis. 2021;80:371-381.
    PubMed         Abstract available
    
    
13. SATO K, Mano T, Iwata A, Toda T, et al
    Safety of Memantine in Combination with Potentially Interactive Drugs in the Real World: A Pharmacovigilance Study Using the Japanese Adverse Drug Event Report (JADER) Database.
    J Alzheimers Dis. 2021;82:1333-1344.
    PubMed         Abstract available
    
    
14. WERBER T, Bata Z, Vaszine ES, Berente DB, et al
    The Association of Periodontitis and Alzheimer's Disease: How to Hit Two Birds with One Stone.
    J Alzheimers Dis. 2021 Sep 8. pii: JAD210491. doi: 10.3233/JAD-210491.
    PubMed         Abstract available
    
    
15. COLATO E, Chiotis K, Ferreira D, Mazrina MS, et al
    Assessment of Tau Pathology as Measured by 18F-THK5317 and 18F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210614. doi: 10.3233/JAD-210614.
    PubMed         Abstract available
    
    
16. SRIWICHAIIN S, Chattipakorn N, Chattipakorn SC
    Metabolomic Alterations in the Blood and Brain in Association with Alzheimer's Disease: Evidence from in vivo to Clinical Studies.
    J Alzheimers Dis. 2021 Sep 9. pii: JAD210737. doi: 10.3233/JAD-210737.
    PubMed         Abstract available
    
    
17. DENNISON JL, Ricciardi NR, Lohse I, Volmar CH, et al
    Sexual Dimorphism in the 3xTg-AD Mouse Model and Its Impact on Pre-Clinical Research.
    J Alzheimers Dis. 2021;80:41-52.
    PubMed         Abstract available
    
    
18. GNANAPRAKASH M, Staniszewski A, Zhang H, Pitstick R, et al
    Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice.
    J Alzheimers Dis. 2021;79:1813-1829.
    PubMed         Abstract available
    
    
19. MARTINEZ-MALDONADO A, Ontiveros-Torres MA, Harrington CR, Montiel-Sosa JF, et al
    Molecular Processing of Tau Protein in Progressive Supranuclear Palsy: Neuronal and Glial Degeneration.
    J Alzheimers Dis. 2021;79:1517-1531.
    PubMed         Abstract available
    
    
20. BASCUNANA P, Brackhan M, Pahnke J
    Machine Learning-Supported Analyses Improve Quantitative Histological Assessments of Amyloid-beta Deposits and Activated Microglia.
    J Alzheimers Dis. 2021;79:597-605.
    PubMed         Abstract available
    
    
21. BERGER M, Cooter M, Roesler AS, Chung S, et al
    APOE4 Copy Number-Dependent Proteomic Changes in the Cerebrospinal Fluid.
    J Alzheimers Dis. 2021;79:511-530.
    PubMed         Abstract available
    
    
22. COSTA AS, Pinho J, Kucikiene D, Reich A, et al
    Cerebral Amyloid Angiopathy in Amyloid-Positive Patients from a Memory Clinic Cohort.
    J Alzheimers Dis. 2021;79:1661-1672.
    PubMed         Abstract available
    
    

    
    J Neurol Neurosurg Psychiatry

23. CHONG JR, Ashton NJ, Karikari TK, Tanaka T, et al
    Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
    J Neurol Neurosurg Psychiatry. 2021 Sep 11. pii: jnnp-2021-327370.
    PubMed         Abstract available
    
    

    
    Nat Rev Neurol

24. BETTCHER BM, Tansey MG, Dorothee G, Heneka MT, et al
    Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus.
    Nat Rev Neurol. 2021 Sep 14. pii: 10.1038/s41582-021-00549.
    PubMed         Abstract available
    
    

    
    Neurobiol Aging

25. SHEPHERD A, Lim JKH, Wong VHY, Zeleznikow-Johnston AM, et al
    Progressive impairments in executive function in the APP/PS1 model of Alzheimer's disease as measured by translatable touchscreen testing.
    Neurobiol Aging. 2021;108:58-71.
    PubMed         Abstract available
    
    
26. PALIWAL D, McInerney TW, Pa J, Swerdlow RH, et al
    Mitochondrial pathway polygenic risk scores are associated with Alzheimer's Disease.
    Neurobiol Aging. 2021 Aug 18. pii: S0197-4580(21)00259.
    PubMed         Abstract available
    
    

    
    Neurochem Res

27. WAN T, Fu M, Jiang Y, Jiang W, et al
    Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease.
    Neurochem Res. 2021 Sep 13. pii: 10.1007/s11064-021-03448.
    PubMed         Abstract available
    
    
28. CAO B, Zeng M, Zhang Q, Zhang B, et al
    Amentoflavone Ameliorates Memory Deficits and Abnormal Autophagy in Abeta25-35-Induced Mice by mTOR Signaling.
    Neurochem Res. 2021;46:921-934.
    PubMed         Abstract available
    
    
29. HACIOGLU C, Kar F, Kanbak G
    Ex Vivo Investigation of Bexarotene and Nicotinamide Function as a Protective Agent on Rat Synaptosomes Treated with Abeta(1-42).
    Neurochem Res. 2021;46:804-818.
    PubMed         Abstract available
    
    

    
    Neurologia (Engl Ed)

30. BELLO-MEDINA PC, Gonzalez-Franco DA, Vargas-Rodriguez I, Diaz-Cintra S, et al
    Oxidative stress, the immune response, synaptic plasticity, and cognition in transgenic models of Alzheimer disease.
    Neurologia (Engl Ed). 2021 Sep 8. pii: S2173-5808(21)00131.
    PubMed         Abstract available
    
    

    
    Neurology

31. SCHINDLER S, Li Y, Buckles VD, Gordon BA, et al
    Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012775.
    PubMed         Abstract available
    
    
32. BUCIUC M, Josephs KA, Jones DT, Whitwell JL, et al
    Progressive Auditory Verbal Agnosia Secondary to Alzheimer Disease.
    Neurology. 2021 Sep 9. pii: WNL.0000000000012783.
    PubMed        
    
    

    
    Neurosci Lett

33. KURIMOTO E, Yamada R, Hirakawa T, Kimura H, et al
    Therapeutic Potential of TAK-071, a Muscarinic M1 Receptor Positive Allosteric Modulator with Low Cooperativity, For the Treatment of Cognitive Deficits and Negative Symptoms Associated with Schizophrenia.
    Neurosci Lett. 2021 Sep 9:136240. doi: 10.1016/j.neulet.2021.136240.
    PubMed         Abstract available
    
    

    
    PLoS Biol

34. LAM V, Takechi R, Hackett MJ, Francis R, et al
    Synthesis of human amyloid restricted to liver results in an Alzheimer disease-like neurodegenerative phenotype.
    PLoS Biol. 2021;19:e3001358.
    PubMed         Abstract available
    
    

    
    PLoS Genet

35. ZHAN L, Li J, Jew B, Sul JH, et al
    Rare variants in the endocytic pathway are associated with Alzheimer's disease, its related phenotypes, and functional consequences.
    PLoS Genet. 2021;17:e1009772.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: